125 results
Page 5 of 7
6-K
EX-1.1
oj7rsyag41jsav hsv
1 Nov 12
Current report (foreign)
12:00am
6-K
EX-99.1
yfr6u1x7rp0t1d8g
27 Sep 12
Drug candidate to be assessed for managing voluntary motor disturbances in Huntington disease
12:00am
6-K
EX-99.1
ppj brzouwmch
30 Aug 12
Teva Announces Fda Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-induced Neutropenia
12:00am
6-K
br4w4nd
8 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
82xxqysa pp106
8 Mar 12
Teva Receives FDA Approval for ProAirĀ® HFA (albuterol sulfate) with Dose Counter
12:00am
6-K
rz24u
17 May 11
Teva and Curetech Announce Positive Phase II Data from CT-011, an Investigational Antibody In Diffuse Large B Cell Lymphoma
12:00am
6-K
EX-2.1
qto01w1wrhotp 0590
3 May 11
Teva Pharmaceutical Industries Limited 6-K
12:00am
S-8
EX-99.1
9wxf22 hr2n3mb2n
27 Jul 10
Registration of securities for employees
12:00am
6-K
x8ccptudsf dq
18 May 10
Current report (foreign)
12:00am
6-K
7dusvqldhdydogplve
17 May 10
Teva Provides Update on Talampanel for the Treatmentof Amyotrophic Lateral Sclerosis (Als)
12:00am
6-K
eaj7p1ji91qk
22 Dec 08
Current report (foreign)
12:00am
6-K
8wn8v mwdi9cygif4
5 Dec 08
Current report (foreign)
12:00am
F-4/A
wg5nsyxcihs jf38cfo
14 Oct 08
Registration of securities (foreign) (amended)
12:00am
F-4
o6n7eic20kbz b3csmr
16 Sep 08
Registration of securities (foreign)
12:00am
6-K
EX-2
cu1dzms yrfk
18 Jul 08
Report of Foreign Private Issuer
12:00am
425
EX-2.1
txf9b6
18 Jul 08
Business combination disclosure
12:00am